These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O, AmarCand Study Group. Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476 [Abstract] [Full Text] [Related]
4. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005. Borg-von Zepelin M, Kunz L, Rüchel R, Reichard U, Weig M, Gross U. J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683 [Abstract] [Full Text] [Related]
7. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. Parkins MD, Sabuda DM, Elsayed S, Laupland KB. J Antimicrob Chemother; 2007 Sep; 60(3):613-8. PubMed ID: 17576697 [Abstract] [Full Text] [Related]
8. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, Edwards JE. Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728 [Abstract] [Full Text] [Related]
9. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Hachem R, Hanna H, Kontoyiannis D, Jiang Y, Raad I. Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153 [Abstract] [Full Text] [Related]
10. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Fridkin SK, Kaufman D, Edwards JR, Shetty S, Horan T. Pediatrics; 2006 May; 117(5):1680-7. PubMed ID: 16651324 [Abstract] [Full Text] [Related]
14. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Healy CM, Campbell JR, Zaccaria E, Baker CJ. Pediatrics; 2008 Apr; 121(4):703-10. PubMed ID: 18381534 [Abstract] [Full Text] [Related]
15. [Epidemiology of candidemia: results of a one month French hospitals-based surveillance study in 2004]. Eloy O, Blanc V, Pina P, Gaudart A, Bressolle ML, Plainvert C, Decousser JW, Pangon B, Allouch PY, le Collège de bactériologie virologie hygiène (ColBVH). Pathol Biol (Paris); 2006 Apr; 54(8-9):523-30. PubMed ID: 17029814 [Abstract] [Full Text] [Related]
16. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies. Manzoni P, Leonessa M, Galletto P, Latino MA, Arisio R, Maule M, Agriesti G, Gastaldo L, Gallo E, Mostert M, Farina D. Pediatr Infect Dis J; 2008 Aug; 27(8):731-7. PubMed ID: 18600191 [Abstract] [Full Text] [Related]
17. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Kim MN, Shin JH, Sung H, Lee K, Kim EC, Ryoo N, Lee JS, Jung SI, Park KH, Kee SJ, Kim SH, Shin MG, Suh SP, Ryang DW. Clin Infect Dis; 2009 Mar 15; 48(6):e57-61. PubMed ID: 19193113 [Abstract] [Full Text] [Related]